{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:28:11Z","timestamp":1790101691207,"version":"4.0.1"},"reference-count":338,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 19242"],"award-info":[{"award-number":["IG 19242"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["67\/GR-2010-2319511"],"award-info":[{"award-number":["67\/GR-2010-2319511"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2017.00314","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T04:18:29Z","timestamp":1510633109000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?"],"prefix":"10.3389","volume":"8","author":[{"given":"Roberta","family":"Malaguarnera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Vella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Nicolosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Belfiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","article-title":"A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see comments]","volume":"83","author":"Hundahl","year":"1998","journal-title":"Cancer"},{"key":"B2","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program2015"},{"key":"B3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/cam4.103","article-title":"The changing face of thyroid cancer in a population-based cohort","volume":"2","author":"Pathak","year":"2013","journal-title":"Cancer Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the United States, 1973-2002","volume":"295","author":"Davies","year":"2006","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1002\/cncr.24416","article-title":"Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005","volume":"115","author":"Chen","year":"2009","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1002\/ijc.27497","article-title":"Thyroid cancer in Denmark 1943-2008, before and after iodine supplementation","volume":"131","author":"Blomberg","year":"2012","journal-title":"Int J Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10552-008-9260-4","article-title":"International patterns and trends in thyroid cancer incidence, 1973-2002","volume":"20","author":"Kilfoy","year":"2009","journal-title":"Cancer Causes Control"},{"key":"B8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/MED.0000000000000094","article-title":"Is there really an increased incidence of thyroid cancer?","volume":"21","author":"Brito","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10654-012-9710-x","article-title":"Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis","volume":"27","author":"McNally","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.amjsurg.2009.11.008","article-title":"Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis","volume":"200","author":"Morris","year":"2010","journal-title":"Am J Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.surg.2015.06.015","article-title":"Increase of papillary thyroid microcarcinoma and a plea for restrictive treatment: a retrospective study of 1,391 prospective documented patients","volume":"159","author":"Gschwandtner","year":"2016","journal-title":"Surgery"},{"key":"B12","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.surg.2008.08.035","article-title":"Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period","volume":"144","author":"Hay","year":"2008","journal-title":"Surgery"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1001\/jama.295.9.1011","article-title":"Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure","volume":"295","author":"Imaizumi","year":"2006","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1023\/A:1026312203045","article-title":"Thyroid cancer pooled analysis from 14 case-control studies: what have we learned?","volume":"14","author":"Preston-Martin","year":"2003","journal-title":"Cancer Causes Control"},{"key":"B15","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/ijc.1377","article-title":"Cohort study of thyroid cancer in a San Francisco Bay area population","volume":"93","author":"Iribarren","year":"2001","journal-title":"Int J Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ando.2011.03.025","article-title":"[Epidemiology of thyroid carcinoma over the world]","volume":"72","author":"Leenhardt","year":"2011","journal-title":"Ann Endocrinol (Paris)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/00039896.1981.10667635","article-title":"Volcanoes and carcinoma of the thyroid: a possible association","volume":"36","author":"Kung","year":"1981","journal-title":"Arch Environ Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.14310\/horm.2002.1242","article-title":"The \u2018rings of fire\u2019 and thyroid cancer","volume":"8","author":"Duntas","year":"2009","journal-title":"Hormones (Athens)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fendo.2013.00065","article-title":"Descriptive epidemiology of human thyroid cancer: experience from a regional registry and the \u201cvolcanic factor\u201d","volume":"4","author":"Malandrino","year":"2013","journal-title":"Front Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/S0959-8049(03)00432-5","article-title":"The influence of dietary patterns on the development of thyroid cancer","volume":"39","author":"Markaki","year":"2003","journal-title":"Eur J Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1158\/1055-9965.EPI-10-1220","article-title":"Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies","volume":"20","author":"Kitahara","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1089\/thy.2008.0210","article-title":"Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma","volume":"19","author":"Rego-Iraeta","year":"2009","journal-title":"Thyroid"},{"key":"B23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1200\/JCO.2009.26.4473","article-title":"Associations of insulin resistance and adiponectin with mortality in women with breast cancer","volume":"29","author":"Duggan","year":"2011","journal-title":"J Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.suronc.2016.05.021","article-title":"Obesity and colorectal liver metastases: mechanisms and management","volume":"25","author":"Pathak","year":"2016","journal-title":"Surg Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity and cancer mechanisms: tumor microenvironment and inflammation","volume":"34","author":"Iyengar","year":"2016","journal-title":"J Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1023\/A:1008938520101","article-title":"A pooled analysis of thyroid cancer studies. V. Anthropometric factors","volume":"11","author":"Dal Maso","year":"2000","journal-title":"Cancer Causes Control"},{"key":"B28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1023\/B:CACO.0000016573.79453.ba","article-title":"Obesity and cancer risk among white and black United States veterans","volume":"15","author":"Samanic","year":"2004","journal-title":"Cancer Causes Control"},{"key":"B29","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/sj.bjc.6603249","article-title":"Body size and thyroid cancer in two million Norwegian men and women","volume":"95","author":"Engeland","year":"2006","journal-title":"Br J Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/sj.bjc.6602819","article-title":"Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria","volume":"93","author":"Rapp","year":"2005","journal-title":"Br J Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10552-006-0023-9","article-title":"Relation of body mass index to cancer risk in 362,552 Swedish men","volume":"17","author":"Samanic","year":"2006","journal-title":"Cancer Causes Control"},{"key":"B32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10552-008-9266-y","article-title":"Anthropometric factors in differentiated thyroid cancer in French Polynesia: a case-control study","volume":"20","author":"Brindel","year":"2009","journal-title":"Cancer Causes Control"},{"key":"B34","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1089\/thy.2008.0386","article-title":"Body mass index in the evaluation of thyroid cancer risk","volume":"19","author":"Mijovic","year":"2009","journal-title":"Thyroid"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1089\/thy.2009.0456","article-title":"Pooled analysis of two case-control studies in New Caledonia and French Polynesia of body mass index and differentiated thyroid cancer: the importance of body surface area","volume":"20","author":"Clero","year":"2010","journal-title":"Thyroid"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1002\/ijc.24913","article-title":"Prospective study of body mass index, physical activity and thyroid cancer","volume":"126","author":"Leitzmann","year":"2010","journal-title":"Int J Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/aje\/kwp354","article-title":"Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study","volume":"171","author":"Meinhold","year":"2010","journal-title":"Am J Epidemiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/met.2008.0062","article-title":"Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma","volume":"7","author":"Rezzonico","year":"2009","journal-title":"Metab Syndr Relat Disord"},{"key":"B39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/hed.23848","article-title":"High prevalence of papillary thyroid cancer in Korean women with insulin resistance","volume":"38","author":"Bae","year":"2016","journal-title":"Head Neck"},{"key":"B40","first-page":"1","article-title":"A population-based case-control study of thyroid cancer","volume":"79","author":"Ron","year":"1987","journal-title":"J Natl Cancer Inst"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1200\/JCO.2005.11.726","article-title":"Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study","volume":"23","author":"Oh","year":"2005","journal-title":"J Clin Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s10552-011-9747-2","article-title":"Metabolic factors and risk of thyroid cancer in the metabolic syndrome and cancer project (Me-Can)","volume":"22","author":"Almquist","year":"2011","journal-title":"Cancer Causes Control"},{"key":"B43","doi-asserted-by":"publisher","first-page":"E1004","DOI":"10.1002\/ijc.27601","article-title":"Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study","volume":"131","author":"Rinaldi","year":"2012","journal-title":"Int J Cancer"},{"key":"B44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1365-2265.2012.04506.x","article-title":"Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer","volume":"78","author":"Kim","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.amjoto.2015.02.015","article-title":"Relationship between obesity, diabetes and the risk of thyroid cancer","volume":"36","author":"Oberman","year":"2015","journal-title":"Am J Otolaryngol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/jnci\/89.18.1360","article-title":"Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark","volume":"89","author":"Wideroff","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"B47","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s10552-010-9515-8","article-title":"Diabetes and risk of incident cancer: a large population-based cohort study in Israel","volume":"21","author":"Chodick","year":"2010","journal-title":"Cancer Causes Control"},{"key":"B48","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1089\/thy.2010.0396","article-title":"Diabetes and thyroid cancer risk in the National Institutes of Health-AARP diet and health study","volume":"21","author":"Aschebrook-Kilfoy","year":"2011","journal-title":"Thyroid"},{"key":"B49","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10147-012-0435-3","article-title":"The relationship between glucose metabolism disorders and malignant thyroid disease","volume":"18","author":"Duran","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"E497","DOI":"10.1210\/jc.2012-3335","article-title":"The association between self-reported diabetes and cancer incidence in the NIH-AARP diet and health study","volume":"98","author":"Lai","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/eci.12086","article-title":"Diabetes and thyroid cancer mortality: a 12-year prospective follow-up of Taiwanese","volume":"43","author":"Tseng","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"B52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1756-6614-7-7","article-title":"Prevalence of diabetes mellitus in patients with newly evaluated papillary thyroid cancer","volume":"7","author":"Paulus","year":"2014","journal-title":"Thyroid Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e98135","DOI":"10.1371\/journal.pone.0098135","article-title":"Diabetes mellitus and risk of thyroid cancer: a meta-analysis","volume":"9","author":"Yeo","year":"2014","journal-title":"PLoS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10552-011-9890-9","article-title":"Anthropometric factors and physical activity and risk of thyroid cancer in postmenopausal women","volume":"23","author":"Kabat","year":"2012","journal-title":"Cancer Causes Control"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/ijc.26161","article-title":"Body fat distribution, weight change during adulthood, and thyroid cancer risk in the NIH-AARP diet and health study","volume":"130","author":"Kitahara","year":"2012","journal-title":"Int J Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1089\/thy.2015.0319","article-title":"Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies","volume":"26","author":"Kitahara","year":"2016","journal-title":"Thyroid"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1177\/030006051204000601","article-title":"Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies","volume":"40","author":"Zhao","year":"2012","journal-title":"J Int Med Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.surg.2014.04.020","article-title":"The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices","volume":"156","author":"Tresallet","year":"2014","journal-title":"Surgery"},{"key":"B59","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1001\/archsurg.2012.713","article-title":"Risk of advanced papillary thyroid cancer in obese patients","volume":"147","author":"Harari","year":"2012","journal-title":"Arch Surg"},{"key":"B60","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1210\/jc.2010-0440","article-title":"The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study","volume":"95","author":"Paes","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.2741\/3810","article-title":"Associations between adipokines and obesity-related cancer","volume":"16","author":"Paz-Filho","year":"2011","journal-title":"Front Biosci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.3892\/or_00000817","article-title":"Differential roles of leptin in regulating cell migration in thyroid cancer cells","volume":"23","author":"Cheng","year":"2010","journal-title":"Oncol Rep"},{"key":"B63","first-page":"637","article-title":"Role of leptin and its receptors in the pathogenesis of thyroid cancer","volume":"4","author":"Uddin","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/obr.12070","article-title":"Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms","volume":"14","author":"Pazaitou-Panayiotou","year":"2013","journal-title":"Obes Rev"},{"key":"B65","doi-asserted-by":"publisher","first-page":"E2023","DOI":"10.1210\/jc.2010-1908","article-title":"Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies","volume":"96","author":"Mitsiades","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1046\/j.1365-2265.2002.01543.x","article-title":"Serum leptin concentrations of patients with sequential thyroid function changes","volume":"57","author":"Hsieh","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S1015-9584(09)60397-3","article-title":"Leptin levels in thyroid cancer","volume":"32","author":"Akinci","year":"2009","journal-title":"Asian J Surg"},{"key":"B68","doi-asserted-by":"publisher","first-page":"832163","DOI":"10.4061\/2011\/832163","article-title":"Leptin: a correlated peptide to papillary thyroid carcinoma?","volume":"2011","author":"Hedayati","year":"2011","journal-title":"J Thyroid Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.surg.2009.11.004","article-title":"Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma","volume":"147","author":"Cheng","year":"2010","journal-title":"Surgery"},{"key":"B70","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.metabol.2009.06.032","article-title":"Circulating adiponectin concentrations were related to free thyroxine levels in thyroid cancer patients after thyroid hormone withdrawal","volume":"59","author":"Lin","year":"2010","journal-title":"Metabolism"},{"key":"B71","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2010.02.006","article-title":"Insulin resistance and lower plasma adiponectin increase malignancy risk in nondiabetic continuous ambulatory peritoneal dialysis patients","volume":"60","author":"Park","year":"2011","journal-title":"Metabolism"},{"key":"B72","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12013-012-9419-1","article-title":"Expression and biologic significance of adiponectin receptors in papillary thyroid carcinoma","volume":"65","author":"Cheng","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"B73","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1089\/thy.2013.0470","article-title":"Risk-based ultrasound screening for thyroid cancer in obese patients is cost-effective","volume":"24","author":"Cham","year":"2014","journal-title":"Thyroid"},{"key":"B74","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1210\/edrv.22.5.0444","article-title":"Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models","volume":"22","author":"Kimura","year":"2001","journal-title":"Endocr Rev"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1210\/jc.2006-0527","article-title":"Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration","volume":"91","author":"Boelaert","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B76","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1210\/jc.2007-2215","article-title":"Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage","volume":"93","author":"Haymart","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1677\/ERC-09-0036","article-title":"Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role","volume":"16","author":"Fiore","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1210\/endo-119-2-940","article-title":"Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves\u2019-IgG","volume":"119","author":"Tramontano","year":"1986","journal-title":"Endocrinology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1210\/jcem-68-5-899","article-title":"Epidermal growth factor receptors in plasma membranes of normal and diseased human thyroid glands","volume":"68","author":"Kanamori","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"B80","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/bjc.1992.177","article-title":"Expression of c-erbB-2 protein in papillary thyroid carcinomas","volume":"65","author":"Haugen","year":"1992","journal-title":"Br J Cancer"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1210\/jcem.82.7.4104","article-title":"Negative\/low expression of the Met\/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases","volume":"82","author":"Belfiore","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1210\/jcem.80.3.7533768","article-title":"Expression of fibroblast growth factors in thyroid cancer","volume":"80","author":"Eggo","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B83","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/jcb.240490305","article-title":"Effect of TSH in human thyroid cells: evidence for both mitogenic and antimitogenic effects","volume":"49","author":"Milazzo","year":"1992","journal-title":"J Cell Biochem"},{"key":"B84","doi-asserted-by":"publisher","first-page":"15776","DOI":"10.1073\/pnas.242322099","article-title":"Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice","volume":"99","author":"Marians","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B85","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1590\/S0004-27302007000500003","article-title":"TSH signalling and cancer","volume":"51","author":"Garcia-Jimenez","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1210\/en.2004-0501","article-title":"Minireview: thyrotropin receptor signaling in development and differentiation of the thyroid gland: insights from mouse models and human diseases","volume":"145","author":"De Felice","year":"2004","journal-title":"Endocrinology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1210\/mend.15.2.0606","article-title":"New signaling pathways for hormones and cyclic adenosine 3\u2019,5\u2019-monophosphate action in endocrine cells","volume":"15","author":"Richards","year":"2001","journal-title":"Mol Endocrinol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1210\/jc.2012-3623","article-title":"Thyroid cancer cell resistance to gefitinib depends on the constitutive oncogenic activation of the ERK pathway","volume":"98","author":"Frasca","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B89","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1089\/thy.2000.10.295","article-title":"Role of insulin and serum on thyrotropin regulation of thyroid transcription factor-1 and pax-8 genes expression in FRTL-5 thyroid cells","volume":"10","author":"Medina","year":"2000","journal-title":"Thyroid"},{"key":"B90","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1210\/jc.2010-1255","article-title":"Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid","volume":"96","author":"Malaguarnera","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B91","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1152\/physrev.1992.72.3.667","article-title":"Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors","volume":"72","author":"Dumont","year":"1992","journal-title":"Physiol Rev"},{"key":"B92","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1677\/erc.1.01280","article-title":"IGF1R signalling and its inhibition","volume":"13","author":"Riedemann","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"B93","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1210\/jcem.81.11.8923818","article-title":"Insulin-like growth factor (IGF)-binding proteins in serum \u2013 do they have additional roles besides modulating the endocrine IGF actions?","volume":"81","author":"Mohan","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1210\/mend.6.8.1406708","article-title":"Insulin and insulin-like growth factor I regulate a thyroid-specific nuclear protein that binds to the thyroglobulin promoter","volume":"6","author":"Santisteban","year":"1992","journal-title":"Mol Endocrinol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"23334","DOI":"10.1074\/jbc.272.37.23334","article-title":"Transcriptional control of the forkhead thyroid transcription factor TTF-2 by thyrotropin, insulin, and insulin-like growth factor I","volume":"272","author":"Ortiz","year":"1997","journal-title":"J Biol Chem"},{"key":"B96","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/mp.54.3.121","article-title":"The IGF system in thyroid cancer: new concepts","volume":"54","author":"Vella","year":"2001","journal-title":"Mol Pathol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1210\/jcem.87.1.8142","article-title":"A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer","volume":"87","author":"Vella","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1210\/endo.130.3.1311244","article-title":"Thyrotropin regulates autophosphorylation and kinase activity in both the insulin and the insulin-like growth factor-I receptors in FRTL5 cells","volume":"130","author":"Condorelli","year":"1992","journal-title":"Endocrinology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1128\/MCB.19.5.3278","article-title":"Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells","volume":"19","author":"Frasca","year":"1999","journal-title":"Mol Cell Biol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1038\/sj.onc.1202600","article-title":"Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine\/paracrine mechanism","volume":"18","author":"Sciacca","year":"1999","journal-title":"Oncogene"},{"key":"B101","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1530\/ERC-11-0074","article-title":"Insulin receptor and cancer","volume":"18","author":"Belfiore","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"B102","first-page":"1935","article-title":"Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin\/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling","volume":"5","author":"Pandini","year":"1999","journal-title":"Clin Cancer Res"},{"key":"B103","first-page":"3736","article-title":"Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer","volume":"53","author":"Papa","year":"1993","journal-title":"Cancer Res"},{"key":"B104","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1055\/s-2004-814152","article-title":"Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with estrogen receptors alpha and beta","volume":"35","author":"Koda","year":"2003","journal-title":"Horm Metab Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fendo.2011.00093","article-title":"The insulin receptor: a new target for cancer therapy","volume":"2","author":"Malaguarnera","year":"2011","journal-title":"Front Endocrinol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3181\/0809-RM-284","article-title":"Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer","volume":"234","author":"Chakravarty","year":"2009","journal-title":"Exp Biol Med (Maywood)"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e6393","DOI":"10.1097\/MD.0000000000006393","article-title":"Expression characteristics of proteins of IGF-1R, p-Akt, and survivin in papillary thyroid carcinoma patients with type 2 diabetes mellitus","volume":"96","author":"Yan","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"E1168","DOI":"10.1210\/JC.2014-4163","article-title":"Thyrospheres from normal or malignant thyroid tissue have different biological, functional, and genetic features","volume":"100","author":"Giani","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B109","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1210\/jc.2010-1245","article-title":"Thyroid and obesity: an intriguing relationship","volume":"95","author":"Biondi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-017-2792-5","article-title":"Effect of weight loss after bariatric surgery on thyroid-stimulating hormone levels in patients with morbid obesity and normal thyroid function","author":"Neves","year":"2017","journal-title":"Obes Surg"},{"key":"B111","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1365-2265.2005.02247.x","article-title":"Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women","volume":"62","author":"Iacobellis","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B112","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1210\/jc.2008-0823","article-title":"Thyroid function and structure are affected in childhood obesity","volume":"93","author":"Radetti","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B113","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1046\/j.1365-2265.2003.01836.x","article-title":"The effect of body weight and weight loss on thyroid volume and function in obese women","volume":"59","author":"Sari","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B114","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/adc.87.4.320","article-title":"Thyroid hormones before and after weight loss in obesity","volume":"87","author":"Reinehr","year":"2002","journal-title":"Arch Dis Child"},{"key":"B115","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000129678","article-title":"Thyroid hormones and their relation to weight status","volume":"70","author":"Reinehr","year":"2008","journal-title":"Horm Res"},{"key":"B116","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/thy.2006.16.73","article-title":"Thyroid function in humans with morbid obesity","volume":"16","author":"Michalaki","year":"2006","journal-title":"Thyroid"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2016.12.020","article-title":"Associations among insulin resistance, triacylglycerol\/high density lipoprotein (TAG\/HDL ratio) and thyroid hormone levels \u2013 a study on type 2 diabetes mellitus in obese and overweight subjects","author":"Jayanthi","year":"2016","journal-title":"Diabetes Metab Syndr"},{"key":"B118","doi-asserted-by":"publisher","first-page":"36124","DOI":"10.1074\/jbc.M003549200","article-title":"Leptin regulates prothyrotropin-releasing hormone biosynthesis. Evidence for direct and indirect pathways","volume":"275","author":"Nillni","year":"2000","journal-title":"J Biol Chem"},{"key":"B119","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/0026-0495(80)90097-9","article-title":"Nature of suppressed TSH secretion during undernutrition: effect of fasting and refeeding on TSH responses to prolonged TRH infusions","volume":"29","author":"Burman","year":"1980","journal-title":"Metabolism"},{"key":"B120","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1172\/JCI10741","article-title":"Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling","volume":"107","author":"Harris","year":"2001","journal-title":"J Clin Invest"},{"key":"B121","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fendo.2014.00215","article-title":"Type 3 deiodinase: role in cancer growth, stemness, and metabolism","volume":"5","author":"Ciavardelli","year":"2014","journal-title":"Front Endocrinol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1055\/s-0042-121421","article-title":"Thyroid function in human obesity: underlying mechanisms","volume":"48","author":"Fontenelle","year":"2016","journal-title":"Horm Metab Res"},{"key":"B123","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1093\/humrep\/dep285","article-title":"Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome","volume":"24","author":"Mueller","year":"2009","journal-title":"Hum Reprod"},{"key":"B124","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1055\/s-0037-1601436","article-title":"Thyroid-stimulating hormone and insulin resistance: their association with polycystic ovary syndrome without overt hypothyroidism","volume":"39","author":"Benetti-Pinto","year":"2017","journal-title":"Rev Bras Ginecol Obstet"},{"key":"B125","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3109\/09513590.2015.1062864","article-title":"Impact of elevated thyroid-stimulating hormone levels in polycystic ovary syndrome","volume":"31","author":"Trummer","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1080\/09513590.2016.1273895","article-title":"The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome","volume":"33","author":"Yin","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4103\/2230-8210.109714","article-title":"Thyroid disorders in polycystic ovarian syndrome subjects: a tertiary hospital based cross-sectional study from Eastern India","volume":"17","author":"Sinha","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2017.07.010","article-title":"Association of divalent cations and insulin resistance with thyroid hormones in patients with type 2 diabetes mellitus","author":"Jayanthi","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2016.12.041","article-title":"Association between thyroid hormone parameters and dyslipidemia among type 2 diabetes mellitus patients: comparative cross-sectional study","author":"Wolide","year":"2016","journal-title":"Diabetes Metab Syndr"},{"key":"B130","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1620\/tjem.224.173","article-title":"Higher serum free triiodothyronine levels within the normal range are associated with metabolic syndrome components in type 2 diabetic subjects with euthyroidism","volume":"224","author":"Taneichi","year":"2011","journal-title":"Tohoku J Exp Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1507\/endocrj.K10E-272","article-title":"The relationship between serum thyrotropin and components of metabolic syndrome","volume":"58","author":"Lai","year":"2011","journal-title":"Endocr J"},{"key":"B132","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1210\/jc.2006-1718","article-title":"Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects","volume":"92","author":"Roos","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B133","doi-asserted-by":"publisher","first-page":"394","DOI":"10.5603\/EP.2015.0049","article-title":"Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6","volume":"66","author":"Sieminska","year":"2015","journal-title":"Endokrynol Pol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1089\/thy.2014.0103","article-title":"Serum free thyroxine concentration is associated with metabolic syndrome in euthyroid subjects","volume":"24","author":"Mehran","year":"2014","journal-title":"Thyroid"},{"key":"B135","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.fertnstert.2012.10.006","article-title":"Subclinical hypothyroidism in young women with polycystic ovary syndrome: an analysis of clinical, hormonal, and metabolic parameters","volume":"99","author":"Benetti-Pinto","year":"2013","journal-title":"Fertil Steril"},{"key":"B136","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11695-014-1313-z","article-title":"Iodine deficiency is higher in morbid obesity in comparison with late after bariatric surgery and non-obese women","volume":"25","author":"Lecube","year":"2015","journal-title":"Obes Surg"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/j.1365-2362.2011.02526.x","article-title":"Thyroid hormone levels predict the change in body weight: a prospective study","volume":"41","author":"Soriguer","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"B138","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000322075","article-title":"Relationship between thyroid volume and iodine, leptin, and adiponectin in obese women before and after weight loss","volume":"20","author":"Eray","year":"2011","journal-title":"Med Princ Pract"},{"key":"B139","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1055\/s-0032-1323816","article-title":"Urinary iodine is associated with insulin resistance in subjects with diabetes mellitus type 2","volume":"120","author":"Al-Attas","year":"2012","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/aje\/kwr455","article-title":"Association of childhood obesity with maternal exposure to ambient air polycyclic aromatic hydrocarbons during pregnancy","volume":"175","author":"Rundle","year":"2012","journal-title":"Am J Epidemiol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/1354750032000158420","article-title":"Dioxin\/polychlorinated biphenyl body burden, diabetes and endometriosis: findings in a population-based study in Belgium","volume":"8","author":"Fierens","year":"2003","journal-title":"Biomarkers"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.2337\/dc08-0850","article-title":"Association of brominated flame retardants with diabetes and metabolic syndrome in the U.S. population, 2003-2004","volume":"31","author":"Lim","year":"2008","journal-title":"Diabetes Care"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.2337\/dc06-0543","article-title":"A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002","volume":"29","author":"Lee","year":"2006","journal-title":"Diabetes Care"},{"key":"B144","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.2337\/db15-1567","article-title":"Association between long-term exposure to air pollution and biomarkers related to insulin resistance, subclinical inflammation, and adipokines","volume":"65","author":"Wolf","year":"2016","journal-title":"Diabetes"},{"key":"B145","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/00001648-199705000-00005","article-title":"Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand","volume":"8","author":"Henriksen","year":"1997","journal-title":"Epidemiology"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.2337\/dc10-2116","article-title":"Polychlorinated biphenyls and organochlorine pesticides in plasma predict development of type 2 diabetes in the elderly: the prospective investigation of the vasculature in uppsala seniors (PIVUS) study","volume":"34","author":"Lee","year":"2011","journal-title":"Diabetes Care"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1289\/ehp.0901689","article-title":"Traffic-related air pollution and incident type 2 diabetes: results from the SALIA cohort study","volume":"118","author":"Kramer","year":"2010","journal-title":"Environ Health Perspect"},{"key":"B148","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12940-015-0031-x","article-title":"Long-term exposure to fine particulate matter and incidence of type 2 diabetes mellitus in a cohort study: effects of total and traffic-specific air pollution","volume":"14","author":"Weinmayr","year":"2015","journal-title":"Environ Health"},{"key":"B149","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.envint.2016.12.011","article-title":"Ambient ozone and incident diabetes: a prospective analysis in a large cohort of African American women","volume":"102","author":"Jerrett","year":"2017","journal-title":"Environ Int"},{"key":"B150","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/CIRCULATIONAHA.111.052753","article-title":"Air pollution and incidence of hypertension and diabetes mellitus in black women living in Los Angeles","volume":"125","author":"Coogan","year":"2012","journal-title":"Circulation"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1001\/jama.300.11.1303","article-title":"Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults","volume":"300","author":"Lang","year":"2008","journal-title":"JAMA"},{"key":"B152","doi-asserted-by":"publisher","first-page":"622","DOI":"10.2337\/dc06-2190","article-title":"Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002","volume":"30","author":"Lee","year":"2007","journal-title":"Diabetes Care"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00125-007-0755-4","article-title":"Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002","volume":"50","author":"Lee","year":"2007","journal-title":"Diabetologia"},{"key":"B154","doi-asserted-by":"publisher","first-page":"E480","DOI":"10.1210\/jc.2010-1658","article-title":"Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS","volume":"96","author":"Kandaraki","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B155","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1111\/apa.12885","article-title":"The endocrine disruptor bisphenol A may play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls","volume":"104","author":"Akin","year":"2015","journal-title":"Acta Paediatr"},{"key":"B156","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-2265.2012.04500.x","article-title":"Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis","volume":"78","author":"Tarantino","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B157","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0015-0282(16)56633-3","article-title":"Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia","volume":"61","author":"Rajkhowa","year":"1994","journal-title":"Fertil Steril"},{"key":"B158","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1006\/bbrc.2002.6407","article-title":"Serum bisphenol A concentrations showed gender differences, possibly linked to androgen levels","volume":"291","author":"Takeuchi","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"B159","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1507\/endocrj.51.165","article-title":"Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction","volume":"51","author":"Takeuchi","year":"2004","journal-title":"Endocr J"},{"key":"B160","doi-asserted-by":"publisher","first-page":"13240","DOI":"10.3390\/ijerph121013240","article-title":"Associations between bisphenol A exposure and reproductive hormones among female workers","volume":"12","author":"Miao","year":"2015","journal-title":"Int J Environ Res Public Health"},{"key":"B161","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1530\/EJE-08-0734","article-title":"Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism?","volume":"160","author":"Rotondi","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00592-006-0204-8","article-title":"Thyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics","volume":"43","author":"Akbar","year":"2006","journal-title":"Acta Diabetol"},{"key":"B163","first-page":"751","article-title":"Pattern of thyroid autoimmunity in type 1 and type 2 diabetics","volume":"16","author":"Yasmin","year":"2006","journal-title":"J Coll Physicians Surg Pak"},{"key":"B164","doi-asserted-by":"publisher","first-page":"710363","DOI":"10.1155\/2015\/710363","article-title":"Thyroid autoimmunity in the context of type 2 diabetes mellitus: implications for vitamin D","volume":"2015","author":"Toulis","year":"2015","journal-title":"Int J Endocrinol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12902-016-0152-4","article-title":"Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study","volume":"17","author":"Sarfo-Kantanka","year":"2017","journal-title":"BMC Endocr Disord"},{"key":"B166","doi-asserted-by":"publisher","first-page":"e17954","DOI":"10.5812\/ijem.17954","article-title":"Detection of thyroid autoimmunity markers in euthyroid women with polycystic ovary syndrome: a case-control study from Syria","volume":"12","author":"Al-Saab","year":"2014","journal-title":"Int J Endocrinol Metab"},{"key":"B167","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1530\/eje.0.1500363","article-title":"High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome","volume":"150","author":"Janssen","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s13224-016-0914-y","article-title":"Antithyroid peroxidase antibodies in women with polycystic ovary syndrome","volume":"67","author":"Menon","year":"2017","journal-title":"J Obstet Gynaecol India"},{"key":"B169","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejogrb.2013.03.003","article-title":"High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome","volume":"169","author":"Garelli","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00404-011-2040-5","article-title":"Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome","volume":"285","author":"Kachuei","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"B171","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3109\/09513590.2014.958990","article-title":"Polycystic ovary syndrome and chronic autoimmune thyroiditis","volume":"31","author":"Novais Jde","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3109\/07435800.2015.1015730","article-title":"High prevalence of Hashimoto\u2019s thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role?","volume":"40","author":"Arduc","year":"2015","journal-title":"Endocr Res"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1530\/EJE-09-1012","article-title":"High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case-control study","volume":"162","author":"Ganie","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1210\/jc.2014-2723","article-title":"The association between insulin resistance and vascularization of thyroid nodules","volume":"100","author":"Wang","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B175","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1152\/physrev.00030.2014","article-title":"Obesity and diabetes: the increased risk of cancer and cancer-related mortality","volume":"95","author":"Gallagher","year":"2015","journal-title":"Physiol Rev"},{"key":"B176","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/164_2015_12","article-title":"Metabolic syndrome, type 2 diabetes, and cancer: epidemiology and potential mechanisms","volume":"233","author":"Ben-Shmuel","year":"2016","journal-title":"Handb Exp Pharmacol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1530\/ERC-14-0490","article-title":"Highly specific role of the insulin receptor in breast cancer progression","volume":"22","author":"Rostoker","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"B178","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1530\/ERC-16-0142","article-title":"EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice","volume":"23","author":"Zelenko","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"B179","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.2337\/db13-0249","article-title":"Insulin receptor phosphorylation by endogenous insulin or the insulin analog AspB10 promotes mammary tumor growth independent of the IGF-I receptor","volume":"62","author":"Gallagher","year":"2013","journal-title":"Diabetes"},{"key":"B180","doi-asserted-by":"publisher","first-page":"16084","DOI":"10.18632\/oncotarget.3177","article-title":"Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses","volume":"6","author":"Malaguarnera","year":"2015","journal-title":"Oncotarget"},{"key":"B181","doi-asserted-by":"publisher","first-page":"43248","DOI":"10.18632\/oncotarget.18020","article-title":"Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells","volume":"8","author":"Vella","year":"2017","journal-title":"Oncotarget"},{"key":"B182","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1530\/ERC-14-0245","article-title":"GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts","volume":"21","author":"De Marco","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"B183","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.18632\/oncotarget.6524","article-title":"IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K\/AKT pathway","volume":"7","author":"Mata","year":"2016","journal-title":"Oncotarget"},{"key":"B184","doi-asserted-by":"publisher","first-page":"21695","DOI":"10.1074\/jbc.M000805200","article-title":"Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways","volume":"275","author":"Miele","year":"2000","journal-title":"J Biol Chem"},{"key":"B185","doi-asserted-by":"publisher","first-page":"R225","DOI":"10.1530\/ERC-12-0203","article-title":"The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression","volume":"19","author":"Rose","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"B186","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13044-015-0020-8","article-title":"Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies","volume":"8","author":"Zimmermann","year":"2015","journal-title":"Thyroid Res"},{"key":"B187","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S2213-8587(14)70225-6","article-title":"Iodine deficiency and thyroid disorders","volume":"3","author":"Zimmermann","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1089\/thy.1998.8.1179","article-title":"Epidemiology of thyroid diseases in iodine sufficiency","volume":"8","author":"Lind","year":"1998","journal-title":"Thyroid"},{"key":"B189","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1089\/thy.2009.0404","article-title":"Lower incidence of anaplastic carcinoma after higher iodination of salt in Slovenia","volume":"20","author":"Besic","year":"2010","journal-title":"Thyroid"},{"key":"B190","doi-asserted-by":"publisher","first-page":"965212","DOI":"10.1155\/2013\/965212","article-title":"Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors","volume":"2013","author":"Pellegriti","year":"2013","journal-title":"J Cancer Epidemiol"},{"key":"B191","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/ncpendmet0621","article-title":"Mechanisms of disease: hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors","volume":"3","author":"Krohn","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B192","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1089\/thy.2011.0387","article-title":"Iodine-deficiency-induced long lasting angiogenic reaction in thyroid cancers occurs via a vascular endothelial growth factor-hypoxia inducible factor-1-dependent, but not a reactive oxygen species-dependent, pathway","volume":"22","author":"Gerard","year":"2012","journal-title":"Thyroid"},{"key":"B193","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1210\/en.2015-1911","article-title":"Involvement of mTOR and regulation by AMPK in early iodine deficiency-induced thyroid microvascular activation","volume":"157","author":"Craps","year":"2016","journal-title":"Endocrinology"},{"key":"B194","first-page":"70","article-title":"[Correlation between adipocytokines with iodine deficiency criteria in patients with metabolic syndrome and type 2 diabetes mellitus in Carpathians region]","author":"Skrypnyk","year":"2010","journal-title":"Lik Sprava"},{"key":"B195","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3923\/pjbs.2011.412.424","article-title":"A review on the metabolic disorders of iodine deficiency","volume":"14","author":"Mansourian","year":"2011","journal-title":"Pak J Biol Sci"},{"key":"B196","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1365-2265.2008.03291.x","article-title":"Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism","volume":"70","author":"Boelaert","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1093\/jnci\/djp354","article-title":"Papillary thyroid cancer incidence in the volcanic area of Sicily","volume":"101","author":"Pellegriti","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"B198","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/00039896.1986.9935763","article-title":"Thyroid cancer incidence in relation to volcanic activity","volume":"41","author":"Arnbjornsson","year":"1986","journal-title":"Arch Environ Health"},{"key":"B199","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrendo.2011.56","article-title":"Endocrine disruptors in the etiology of type 2 diabetes mellitus","volume":"7","author":"Alonso-Magdalena","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"B200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JME-08-0132","article-title":"Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders","volume":"43","author":"Swedenborg","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"B201","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev-physiol-012110-142200","article-title":"Endocrine disruptors: from endocrine to metabolic disruption","volume":"73","author":"Casals-Casas","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrendo.2016.168","article-title":"Endocrine disruptors: air pollution linked to insulin resistance","volume":"12","author":"Holmes","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2174\/156800908786241104","article-title":"Interaction between estrogen receptor alpha and insulin\/IGF signaling in breast cancer","volume":"8","author":"Lanzino","year":"2008","journal-title":"Curr Cancer Drug Targets"},{"key":"B204","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1210\/er.2009-0002","article-title":"Endocrine-disrupting chemicals: an endocrine society scientific statement","volume":"30","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Endocr Rev"},{"key":"B205","first-page":"3232","article-title":"Endogenous hormones as a major factor in human cancer","volume":"42","author":"Henderson","year":"1982","journal-title":"Cancer Res"},{"key":"B206","doi-asserted-by":"publisher","first-page":"T273","DOI":"10.1530\/ERC-14-0053","article-title":"Estrogen and its role in thyroid cancer","volume":"21","author":"Derwahl","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"B207","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/toxsci\/kfw064","article-title":"Arsenite and cadmium activate MAPK\/ERK via membrane estrogen receptors and G-protein coupled estrogen receptor signaling in human lung adenocarcinoma cells","volume":"152","author":"Huff","year":"2016","journal-title":"Toxicol Sci"},{"key":"B208","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.taap.2007.12.017","article-title":"Rapid activation of ERK1\/2 and AKT in human breast cancer cells by cadmium","volume":"228","author":"Liu","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"B209","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mce.2017.02.045","article-title":"Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer","volume":"457","author":"Di Donato","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1289\/ehp.1205826","article-title":"Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions","volume":"121","author":"Vinas","year":"2013","journal-title":"Environ Health Perspect"},{"key":"B211","doi-asserted-by":"publisher","first-page":"7270","DOI":"10.1158\/0008-5472.CAN-09-0088","article-title":"Role of cyclic AMP response element-binding protein in insulin-like growth factor-I receptor up-regulation by sex steroids in prostate cancer cells","volume":"69","author":"Genua","year":"2009","journal-title":"Cancer Res"},{"key":"B212","doi-asserted-by":"publisher","first-page":"109","DOI":"10.14310\/horm.2002.1261","article-title":"Autoimmunity in differentiated thyroid cancer: significance and related clinical problems","volume":"9","author":"Feldt-Rasmussen","year":"2010","journal-title":"Hormones (Athens)"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1067\/msy.2099.101431","article-title":"Coexistent Hashimoto\u2019s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome","volume":"126","author":"Singh","year":"1999","journal-title":"Surgery"},{"key":"B214","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1210\/jc.2012-2978","article-title":"Clinical review: Hashimoto\u2019s thyroiditis and papillary thyroid carcinoma: is there a correlation?","volume":"98","author":"Jankovic","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B215","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s13193-014-0325-4","article-title":"Papillary thyroid cancer and Hashimoto\u2019s thyroiditis: an association less understood","volume":"5","author":"Anand","year":"2014","journal-title":"Indian J Surg Oncol"},{"key":"B216","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.tem.2014.09.001","article-title":"Hashimoto\u2019s thyroiditis and papillary thyroid cancer: are they immunologically linked?","volume":"25","author":"Ehlers","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"B217","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1210\/jc.2009-2798","article-title":"Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants","volume":"95","author":"Marzullo","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B218","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"B219","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00432-008-0373-7","article-title":"Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules","volume":"134","author":"Polyzos","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"B220","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/02841850600806308","article-title":"Thyroid ultrasound in diabetic patients without overt thyroid disease","volume":"47","author":"Junik","year":"2006","journal-title":"Acta Radiol"},{"key":"B221","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1590\/S0004-27302005000200009","article-title":"[Thyroid disorders in diabetic patients]","volume":"49","author":"Pimenta","year":"2005","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B222","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1590\/0004-2730000003418","article-title":"Thyroid volume in patients with glucose metabolism disorders","volume":"58","author":"Duran","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B223","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1089\/met.2014.0158","article-title":"Association between worse metabolic control and increased thyroid volume and nodular disease in elderly adults with metabolic syndrome","volume":"13","author":"Blanc","year":"2015","journal-title":"Metab Syndr Relat Disord"},{"key":"B224","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.metabol.2013.01.009","article-title":"Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area","volume":"62","author":"Anil","year":"2013","journal-title":"Metabolism"},{"key":"B225","first-page":"1","article-title":"State-specific prevalence of selected chronic disease-related characteristics \u2013 behavioral risk factor surveillance system, 2001","volume":"52","author":"Ahluwalia","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"B226","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s00125-011-2242-1","article-title":"Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias","volume":"54","author":"Johnson","year":"2011","journal-title":"Diabetologia"},{"key":"B227","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF00051670","article-title":"Cancer risk in patients with diabetes mellitus","volume":"2","author":"Adami","year":"1991","journal-title":"Cancer Causes Control"},{"key":"B228","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1634\/theoncologist.2009-0300","article-title":"Risk of cancer following hospitalization for type 2 diabetes","volume":"15","author":"Hemminki","year":"2010","journal-title":"Oncologist"},{"key":"B229","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/ije\/dyp186","article-title":"Cohort profile: the metabolic syndrome and cancer project (Me-Can)","volume":"39","author":"Stocks","year":"2010","journal-title":"Int J Epidemiol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/bjc.1994.427","article-title":"A case-control study of diabetes mellitus and cancer risk","volume":"70","author":"La Vecchia","year":"1994","journal-title":"Br J Cancer"},{"key":"B231","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12032-009-9189-9","article-title":"Glucose metabolism disorders in cancer patients in a Chinese population","volume":"27","author":"Zhan","year":"2010","journal-title":"Med Oncol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/01.cej.0000228404.37858.40","article-title":"Diabetes and cancer risk for all and specific sites among Japanese men and women","volume":"16","author":"Kuriki","year":"2007","journal-title":"Eur J Cancer Prev"},{"key":"B233","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1001\/archinte.166.17.1871","article-title":"Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan","volume":"166","author":"Inoue","year":"2006","journal-title":"Arch Intern Med"},{"key":"B234","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1210\/jc.2015-3901","article-title":"Diabetes, diabetes treatment, and risk of thyroid cancer","volume":"101","author":"Luo","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B235","doi-asserted-by":"crossref","first-page":"s867","DOI":"10.1093\/ajcn\/86.3.867S","article-title":"Metabolic syndrome, hyperinsulinemia, and cancer","volume":"86","author":"Hsu","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"B236","first-page":"15","article-title":"Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus","volume":"27","author":"Celani","year":"1994","journal-title":"Diabetes Res"},{"key":"B237","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0968-0004(98)01344-9","article-title":"Oncogenic alterations of metabolism","volume":"24","author":"Dang","year":"1999","journal-title":"Trends Biochem Sci"},{"key":"B238","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2353\/ajpath.2006.051090","article-title":"The metabolic syndrome: a high-risk state for cancer?","volume":"169","author":"Cowey","year":"2006","journal-title":"Am J Pathol"},{"key":"B239","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4312-5","article-title":"Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study","author":"But","year":"2017","journal-title":"Diabetologia"},{"key":"B241","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/eci.12290","article-title":"Treatment with human insulin does not increase thyroid cancer risk in patients with type 2 diabetes","volume":"44","author":"Tseng","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"B242","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1007\/s00125-011-2190-9","article-title":"Long-term effects of insulin glargine on the risk of breast cancer","volume":"54","author":"Suissa","year":"2011","journal-title":"Diabetologia"},{"key":"B243","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00125-011-2312-4","article-title":"Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study","volume":"55","author":"Ruiter","year":"2012","journal-title":"Diabetologia"},{"key":"B244","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3109\/0284186X.2016.1155736","article-title":"Insulin glargine use and breast cancer risk: associations with cumulative exposure","volume":"55","author":"Peeters","year":"2016","journal-title":"Acta Oncol"},{"key":"B245","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00125-009-1441-5","article-title":"Does diabetes therapy influence the risk of cancer?","volume":"52","author":"Smith","year":"2009","journal-title":"Diabetologia"},{"key":"B246","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.2337\/dc10-0476","article-title":"Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients","volume":"33","author":"Mannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"B247","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1007\/s00125-009-1477-6","article-title":"The longest ever randomised controlled trial of insulin glargine: study design and HbA(1c) findings","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"},{"key":"B248","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2337\/dc06-0997","article-title":"Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin","volume":"29","author":"Bowker","year":"2006","journal-title":"Diabetes Care"},{"key":"B249","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2337\/db09-1371","article-title":"Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry","volume":"59","author":"Yang","year":"2010","journal-title":"Diabetes"},{"key":"B250","doi-asserted-by":"publisher","first-page":"E1170","DOI":"10.1210\/jc.2012-1162","article-title":"Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus","volume":"97","author":"Chang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B251","doi-asserted-by":"publisher","first-page":"e79968","DOI":"10.1371\/journal.pone.0079968","article-title":"Impact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control study","volume":"8","author":"Simo","year":"2013","journal-title":"PLoS One"},{"key":"B252","doi-asserted-by":"publisher","first-page":"e0125421","DOI":"10.1371\/journal.pone.0125421","article-title":"Association between gastroenterological malignancy and diabetes mellitus and anti-diabetic therapy: a nationwide, population-based cohort study","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"B253","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2169\/internalmedicine.52.8276","article-title":"Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan","volume":"52","author":"Chiu","year":"2013","journal-title":"Intern Med"},{"key":"B254","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/2042018814558243","article-title":"Dapagliflozin in patients with type 2 diabetes mellitus","volume":"6","author":"Filippatos","year":"2015","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B255","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1742-1241.2010.02499.x","article-title":"Liraglutide: the therapeutic promise from animal models","volume":"167","author":"Knudsen","year":"2010","journal-title":"Int J Clin Pract Suppl"},{"key":"B256","first-page":"651","article-title":"Familiality of physical and metabolic characteristics that predict the development of non-insulin-dependent diabetes mellitus in Pima Indians","volume":"60","author":"Sakul","year":"1997","journal-title":"Am J Hum Genet"},{"key":"B257","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1210\/jcem.84.4.5604","article-title":"Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds","volume":"84","author":"Elbein","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B258","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000022865","article-title":"Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators","volume":"49","author":"Watanabe","year":"1999","journal-title":"Hum Hered"},{"key":"B259","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s001250050046","article-title":"Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins","volume":"43","author":"Lehtovirta","year":"2000","journal-title":"Diabetologia"},{"key":"B260","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1007\/s00125-005-1892-2","article-title":"Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study","volume":"48","author":"Lin","year":"2005","journal-title":"Diabetologia"},{"key":"B261","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.numecd.2008.11.002","article-title":"\u201cThe Linosa Study\u201d: epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate","volume":"19","author":"Bellia","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B262","first-page":"566","article-title":"Clustering of hypertension, diabetes, and obesity in adult male twins: same genes or same environments?","volume":"55","author":"Carmelli","year":"1994","journal-title":"Am J Hum Genet"},{"key":"B263","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MED.0b013e3283514e13","article-title":"What causes the insulin resistance underlying obesity?","volume":"19","author":"Hardy","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B264","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/cphy.c110025","article-title":"Lack of exercise is a major cause of chronic diseases","volume":"2","author":"Booth","year":"2012","journal-title":"Compr Physiol"},{"key":"B265","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"B266","doi-asserted-by":"publisher","first-page":"C13","DOI":"10.1016\/S1520-765X(03)90045-9","article-title":"Insulin resistance: a global epidemic in need of effective therapies","volume":"5","author":"Califf","year":"2003","journal-title":"Eur Heart J Suppl"},{"key":"B267","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1079\/PHN2003584","article-title":"A life course approach to diet, nutrition and the prevention of chronic diseases","volume":"7","author":"Darnton-Hill","year":"2004","journal-title":"Public Health Nutr"},{"key":"B268","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S1368980001001562","article-title":"Toward public health nutrition strategies in the European Union to implement food based dietary guidelines and to enhance healthier lifestyles","volume":"4","author":"Stockley","year":"2001","journal-title":"Public Health Nutr"},{"key":"B269","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1017\/S1368980009004753","article-title":"Nutrition policy is taking shape in Europe","volume":"12","author":"Trubswasser","year":"2009","journal-title":"Public Health Nutr"},{"key":"B270","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"B271","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.111.039453","article-title":"Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy","volume":"125","author":"Wadden","year":"2012","journal-title":"Circulation"},{"key":"B272","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1053\/meta.2001.24210","article-title":"Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women","volume":"50","author":"McLaughlin","year":"2001","journal-title":"Metabolism"},{"key":"B273","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3945\/jn.111.149393","article-title":"Global iodine status in 2011 and trends over the past decade","volume":"142","author":"Andersson","year":"2012","journal-title":"J Nutr"},{"key":"B274","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"B275","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"B276","doi-asserted-by":"publisher","first-page":"e33411","DOI":"10.1371\/journal.pone.0033411","article-title":"Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis","volume":"7","author":"Noto","year":"2012","journal-title":"PLoS One"},{"key":"B277","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.seminoncol.2015.09.009","article-title":"Repurposing old drugs to chemoprevention: the case of metformin","volume":"43","author":"Heckman-Stoddard","year":"2016","journal-title":"Semin Oncol"},{"key":"B278","doi-asserted-by":"publisher","first-page":"e109852","DOI":"10.1371\/journal.pone.0109852","article-title":"Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes","volume":"9","author":"Tseng","year":"2014","journal-title":"PLoS One"},{"key":"B279","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1186\/s12885-015-1719-6","article-title":"No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study","volume":"15","author":"Becker","year":"2015","journal-title":"BMC Cancer"},{"key":"B280","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/met.2010.0026","article-title":"Metformin treatment for small benign thyroid nodules in patients with insulin resistance","volume":"9","author":"Rezzonico","year":"2011","journal-title":"Metab Syndr Relat Disord"},{"key":"B281","first-page":"1019","article-title":"Effect of metformin on thyroid stimulating hormone and thyroid volume in patients with prediabetes: a randomized placebo-controlled clinical trial","volume":"19","author":"Karimifar","year":"2014","journal-title":"J Res Med Sci"},{"key":"B282","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000442821","article-title":"Metformin decreases thyroid volume and nodule size in subjects with insulin resistance: a preliminary study","volume":"25","author":"Anil","year":"2016","journal-title":"Med Princ Pract"},{"key":"B283","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1530\/JOE-16-0450","article-title":"Metformin and thyroid disease","volume":"233","author":"Meng","year":"2017","journal-title":"J Endocrinol"},{"key":"B284","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1158\/1535-7163.MCT-09-1186","article-title":"Metformin in cancer therapy: a new perspective for an old antidiabetic drug?","volume":"9","author":"Ben Sahra","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"B285","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1210\/jc.2005-1210","article-title":"Thyrotropin suppression by metformin","volume":"91","author":"Vigersky","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B286","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1503\/cmaj.140688","article-title":"Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus","volume":"186","author":"Fournier","year":"2014","journal-title":"CMAJ"},{"key":"B287","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1158\/0008-5472.CAN-04-1837","article-title":"Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells","volume":"65","author":"Pandini","year":"2005","journal-title":"Cancer Res"},{"key":"B288","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1210\/en.2013-1925","article-title":"Metformin inhibits androgen-induced IGF-IR up-regulation in prostate cancer cells by disrupting membrane-initiated androgen signaling","volume":"155","author":"Malaguarnera","year":"2014","journal-title":"Endocrinology"},{"key":"B289","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40880-017-0184-9","article-title":"Metformin targets multiple signaling pathways in cancer","volume":"36","author":"Lei","year":"2017","journal-title":"Chin J Cancer"},{"key":"B290","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.pharep.2016.04.021","article-title":"Molecular targets of metformin antitumor action","volume":"68","author":"Sosnicki","year":"2016","journal-title":"Pharmacol Rep"},{"key":"B291","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1741-7015-9-33","article-title":"Understanding the benefit of metformin use in cancer treatment","volume":"9","author":"Dowling","year":"2011","journal-title":"BMC Med"},{"key":"B292","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"El-Mir","year":"2000","journal-title":"J Biol Chem"},{"key":"B293","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3727\/096504011X13021877989838","article-title":"Antidiabetic drug metformin induces apoptosis in human MCF breast cancer via targeting ERK signaling","volume":"19","author":"Malki","year":"2011","journal-title":"Oncol Res"},{"key":"B294","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1476-5381.2010.01101.x","article-title":"Metformin inhibits P-glycoprotein expression via the NF-kappaB pathway and CRE transcriptional activity through AMPK activation","volume":"162","author":"Kim","year":"2011","journal-title":"Br J Pharmacol"},{"key":"B295","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/j.1476-5381.2010.00762.x","article-title":"Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Calpha-dependent pathway: phorbol-12-myristate-13-acetate-induced\/extracellular signal-regulated kinase\/activator protein-1","volume":"160","author":"Hwang","year":"2010","journal-title":"Br J Pharmacol"},{"key":"B296","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.bjp.0704878","article-title":"Metformin enhances insulin signalling in insulin-dependent and -independent pathways in insulin resistant muscle cells","volume":"137","author":"Kumar","year":"2002","journal-title":"Br J Pharmacol"},{"key":"B297","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2009.03.016","article-title":"Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"key":"B298","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.molcel.2003.08.013","article-title":"TORCs: transducers of regulated CREB activity","volume":"12","author":"Conkright","year":"2003","journal-title":"Mol Cell"},{"key":"B299","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cell.2004.09.015","article-title":"The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector","volume":"119","author":"Screaton","year":"2004","journal-title":"Cell"},{"key":"B300","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/0264-6021:3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem J"},{"key":"B301","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/00498259409043220","article-title":"Accumulation of metformin by tissues of the normal and diabetic mouse","volume":"24","author":"Wilcock","year":"1994","journal-title":"Xenobiotica"},{"key":"B302","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11010-007-9614-3","article-title":"Metformin promotes isolated rat liver mitochondria impairment","volume":"308","author":"Carvalho","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"B303","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2049-3002-2-12","article-title":"Metformin directly acts on mitochondria to alter cellular bioenergetics","volume":"2","author":"Andrzejewski","year":"2014","journal-title":"Cancer Metab"},{"key":"B304","doi-asserted-by":"publisher","first-page":"E510","DOI":"10.1210\/jc.2011-1754","article-title":"Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents","volume":"97","author":"Chen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B305","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1158\/0008-5472.CAN-10-3471","article-title":"Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types","volume":"71","author":"Iliopoulos","year":"2011","journal-title":"Cancer Res"},{"key":"B306","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1158\/1078-0432.CCR-10-2243","article-title":"Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth","volume":"17","author":"Rocha","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B307","first-page":"17","article-title":"Metformin plus PIAF combination chemotherapy for hepatocellular carcinoma","volume":"34","author":"Petrushev","year":"2012","journal-title":"Exp Oncol"},{"key":"B308","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.1007\/s13277-015-3315-4","article-title":"Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway","volume":"36","author":"Han","year":"2015","journal-title":"Tumour Biol"},{"key":"B309","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1210\/jc.2012-3799","article-title":"Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer","volume":"98","author":"Klubo-Gwiezdzinska","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B310","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000437365","article-title":"Metformin is associated with a favorable outcome in diabetic patients with cervical lymph node metastasis of differentiated thyroid cancer","volume":"4","author":"Jang","year":"2015","journal-title":"Eur Thyroid J"},{"key":"B311","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"B312","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1210\/jc.2007-1825","article-title":"Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses","volume":"93","author":"Juurinen","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B313","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.tips.2011.06.006","article-title":"The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact","volume":"32","author":"Phielix","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"B314","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.2337\/diabetes.53.8.2169","article-title":"Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes","volume":"53","author":"Tiikkainen","year":"2004","journal-title":"Diabetes"},{"key":"B315","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.2337\/diabetes.50.10.2316","article-title":"Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats","volume":"50","author":"Hevener","year":"2001","journal-title":"Diabetes"},{"key":"B316","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.2337\/diacare.21.12.2140","article-title":"An autopsy case of troglitazone-induced fulminant hepatitis","volume":"21","author":"Shibuya","year":"1998","journal-title":"Diabetes Care"},{"key":"B317","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"B318","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3109\/07853890.2013.851865","article-title":"Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes","volume":"45","author":"Tseng","year":"2013","journal-title":"Ann Med"},{"key":"B319","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fendo.2017.00031","article-title":"PPAR-gamma agonists as antineoplastic agents in cancers with dysregulated IGF axis","volume":"8","author":"Vella","year":"2017","journal-title":"Front Endocrinol"},{"key":"B320","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/1753-0407.12149","article-title":"Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes 2","volume":"6","author":"Tseng","year":"2014","journal-title":"J Diabetes"},{"key":"B321","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3233\/BD-2003-17108","article-title":"Insulin and hybrid insulin\/IGF receptors are major regulators of breast cancer cells","volume":"17","author":"Frasca","year":"2003","journal-title":"Breast Dis"},{"key":"B322","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1158\/1535-7163.MCT-10-0318","article-title":"Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer","volume":"9","author":"Buck","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"B323","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/er.2017-00073","article-title":"Insulin receptor isoforms in physiology and disease: an updated view","volume":"38","author":"Belfiore","year":"2017","journal-title":"Endocr Rev"},{"key":"B324","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature11154","article-title":"Sequence analysis of mutations and translocations across breast cancer subtypes","volume":"486","author":"Banerji","year":"2012","journal-title":"Nature"},{"key":"B325","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Imielinski","year":"2012","journal-title":"Cell"},{"key":"B326","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/jnci\/djt257","article-title":"Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors","volume":"105","author":"Scott","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"B327","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrd3823","article-title":"The spliceosome as a target of novel antitumour drugs","volume":"11","author":"Bonnal","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"B328","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1074\/jbc.M114.592543","article-title":"The paired basic amino acid-cleaving enzyme 4 (PACE4) is involved in the maturation of insulin receptor isoform B: an opportunity to reduce the specific insulin receptor-dependent effects of insulin-like growth factor 2 (IGF2)","volume":"290","author":"Kara","year":"2015","journal-title":"J Biol Chem"},{"key":"B329","doi-asserted-by":"publisher","first-page":"53442","DOI":"10.1074\/jbc.M407152200","article-title":"Limited redundancy of the proprotein convertase furin in mouse liver","volume":"279","author":"Roebroek","year":"2004","journal-title":"J Biol Chem"},{"key":"B330","doi-asserted-by":"publisher","first-page":"840","DOI":"10.2174\/092986713805076702","article-title":"Polyphenols can inhibit furin in vitro as a result of the reactivity of their auto-oxidation products to proteins","volume":"20","author":"Zhu","year":"2013","journal-title":"Curr Med Chem"},{"key":"B331","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.2174\/1381612823666170622105123","article-title":"Recent advances on the role of microRNAs in both insulin resistance and cancer","volume":"23","author":"Vivacqua","year":"2017","journal-title":"Curr Pharm Des"},{"key":"B332","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ctrv.2011.07.008","article-title":"The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors","volume":"38","author":"Scagliotti","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"B333","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1158\/1535-7163.MCT-06-0509","article-title":"Functional evaluation of novel soluble insulin-like growth factor (IGF)-II-specific ligand traps based on modified domain 11 of the human IGF2 receptor","volume":"6","author":"Prince","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"B334","doi-asserted-by":"publisher","first-page":"E2766","DOI":"10.1073\/pnas.1513023113","article-title":"Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonist","volume":"113","author":"Frago","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B335","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1158\/1535-7163.MCT-14-0751","article-title":"The IGF-Trap: novel inhibitor of carcinoma growth and metastasis","volume":"14","author":"Wang","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"B336","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11892-016-0789-4","article-title":"SGLT2 inhibitors: benefit\/risk balance","volume":"16","author":"Scheen","year":"2016","journal-title":"Curr Diab Rep"},{"key":"B337","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1080\/17512433.2017.1322507","article-title":"A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus","volume":"10","author":"Avogaro","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B338","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00314\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T03:18:03Z","timestamp":1570331883000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00314\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":338,"alternative-id":["10.3389\/fendo.2017.00314"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2017.00314","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]},"article-number":"314"}}